# A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft Versus Host Disease

> **NCT00760981** · PHASE1 · COMPLETED · sponsor: **David Miklos** · enrollment: 15 (actual)

## Conditions studied

- Graft vs Host Disease

## Interventions

- **DRUG:** Imatinib

## Key facts

- **NCT ID:** NCT00760981
- **Lead sponsor:** David Miklos
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00760981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00760981, "A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft Versus Host Disease". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00760981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*